Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.
Blood Cancer Journal
Mithraprabhu, Sridurga S; Reynolds, John J; Turner, Rose R; Quach, Hang H; Horvath, Noemi N; Kerridge, Ian I; Kalff, Anna A; Bergin, Krystal K; Hocking, Jay J; Yuen, Flora F; Khong, Tiffany T; Durie, Brian M BM; Spencer, Andrew A
Molecular Evaluation of Endometrial Dedifferentiated Carcinoma, Endometrioid Carcinoma, Carcinosarcoma, and Serous Carcinoma Using a Custom-Made Small Cancer Panel.
Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing.
Bmc Medical Informatics And Decision Making
Dy, Grace K GK; Nesline, Mary K MK; Papanicolau-Sengos, Antonios A; DePietro, Paul P; LeVea, Charles M CM; Early, Amy A; Chen, Hongbin H; Grand'Maison, Anne A; Boland, Patrick P; Ernstoff, Marc S MS; Edge, Stephen S; Akers, Stacey S; Opyrchal, Mateusz M; Chatta, Gurkamal G; Odunsi, Kunle K; Pabla, Sarabjot S; Conroy, Jeffrey M JM; Glenn, Sean T ST; DeFedericis, Hanchun T HT; Burgher, Blake B; Andreas, Jonathan J; Giamo, Vincent V; Qin, Maochun M; Wang, Yirong Y; Kanehira, Kazunori K; Lenzo, Felicia L FL; Frederick, Peter P; Lele, Shashikant S; Galluzzi, Lorenzo L; Kuvshinoff, Boris B; Morrison, Carl C
Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer.
Gynecologic Oncology Reports
Ngoi, N Y L NYL; Heong, V V; Lee, X W XW; Huang, Y Q YQ; Thian, Y L YL; Choo, B A BA; Lim, D D; Lim, Y W YW; Lim, S E SE; Ilancheran, A A; Soong, R R; Tan, D S P DSP